Merck EVP Maraldo files initial ownership report
Merck & Co., Inc. executive David R. Maraldo reports his equity holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Merck & Co., Inc. executive David R. Maraldo reports his equity holdings. He holds 17,819.434 shares of common stock directly and 8,359.140 shares through a 401(k) plan. He also holds multiple stock options covering 8,060 to 9,709 shares each, with exercise prices from $73.73 to $129.22, plus restricted stock units for 2,361, 581, and 552 shares that vest in scheduled installments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock - 401(k) Plan | -- | -- | -- |
Footnotes (9)
- F1. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025,and 5/2/2026.
- F2. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- F3. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026, and, 4/30/2027.
- F4. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027, and, 4/29/2028.
- F5. The options became exercisable in equal installments in on 5/4/2022, 5/4/2023, and 5/4/2024.
- F6. The options became exercisable in equal installments in on 5/5/2024, 5/5/2025, and 5/5/2026.
- F7. The options vest and become exercisable in equal installments on 5/2/2024, 5/2/2025, and 5/2/2026.
- F8. The options vest and become exercisable in equal installments on 4/30/2025, 4/30/2026, and 4/30/2027.
- F9. The options vest and become exercisable in equal installments on 4/29/2026, 4/29/2027, and 4/29/2028.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
Restricted Stock Unit financial
401(k) Plan financial
exercise price financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the MRK Form 3 filing for David R. Maraldo show?
What stock options for Merck (MRK) are reported for David R. Maraldo?
What restricted stock units does David R. Maraldo have in Merck?
Do the restricted stock units in MRK automatically convert into common stock?
Are there any buy or sell transactions reported in this MRK Form 3?
AI-generated analysis. How Rhea-AI works. Not financial advice.